Sarcoma  >>  patupilone (EPO 906)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
patupilone (EPO 906) / Novartis
NCT00022542: BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma

Terminated
2
26
US
ixabepilone, BMS-247550, epothilone B lactam, Ixempra
National Cancer Institute (NCI)
Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
06/06
06/06
NCT00331643: Ixabepilone in Treating Young Patients With Refractory Solid Tumors

Completed
2
120
US
ixabepilone, BMS-247550, epothilone B lactam, Ixempra
National Cancer Institute (NCI)
Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Synovial Sarcoma, Embryonal Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
10/07
06/09
NCT01168232: Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

Completed
2
42
US
Ixabepilone, (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione, Azaepothilone B, BMS 247550, BMS-247550, BMS247550, Epothilone, Epothilone-B BMS 247550, Ixempra, Laboratory Biomarker Analysis
National Cancer Institute (NCI), NRG Oncology
Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma
11/13
11/13
NCT00045708: A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas

Completed
1/2
57
US
ixabepilone, BMS-247550, epothilone B lactam, Ixempra, pharmacological study, pharmacological studies, Anticonvulsant, P450
National Cancer Institute (NCI)
Adult Anaplastic Astrocytoma, Adult Giant Cell Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
05/10
05/10

Download Options